










The diagnostic yield of computerised tomography in human 
immunodeficiency virus (HIV) positive psychiatric patients at a 






Dr J Berwers 
 
Department of Psychiatry and Mental Health, University of Cape Town 
Student Number BRWJUA001 
 































The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
 2 










List of tables ……………………….……………...……………………………………5 




 Introduction …………………………………………………………………...….……8 
 Aims and objectives …………………………………………………………...……….19 
 Methods ……………………………………………………………………….……….19 
 Study rationale …………………………………………………………………...……21 




 Introduction ………………………………...…………...……………………………..27 
 Methods…………………………………….…………...………………………………28 
 Results ……………………………….…………………………………………………29 
 Discussion …………………………...….……………………………………………...33 
 Conclusion ………………………...…………………………………………………...34  
 References………………………...………………………………………….…………36 





















I, Juan Berwers, hereby declare that the work on which this dissertation/thesis is based is my 
original work (except where acknowledgements indicate otherwise) and that neither the whole 
work nor any part of it has been, is being, or is to be submitted for another degree in this or any 
other university. 
I empower the university to reproduce for the purpose of research either the whole or any portion 
of the contents in any manner whatsoever. 
Signature: 
Date:   10/3/2017 
Signature removed




Background. HIV infection increases the risk for mental illness. Neuroimaging is an 
important part of the diagnostic workup in HIV+ psychiatric patients. Computerised 
tomography (CT) is the most widely neuroimaging modality available in resource 
limited settings. However, not every affected individual requires brain imaging, and 
no clear guidelines exist for the use of CT in psychiatric settings. This retrospective 
study aimed to explore the diagnostic yield of CT brain (CTB) scans in human 
immunodeficiency virus positive (HIV+) psychiatric patients referred to Groote 
Schuur Hospital Department of Psychiatry, as well as demographic and clinical 
associations. 
 
Methods. Clinical and radiological data for HIV+ psychiatric patients who received a 
CTB scan during admission were obtained and analysed for the period January 2013 – 
June 2015. The diagnostic yield- scans with positive findings versus no findings- was 
established and differences between these groups compared.  
 
Results. A total of 65 patients met the inclusion criteria. The mean age of the 
participants in this study was 36.2 years (range 18 – 64). The most common 
presenting psychiatric symptoms were psychosis (81.54%), cognitive deficits 
(72.41%) and mood symptoms (69.23%). CT scan results consisted of 29 (44.62%) 
normal scans and 36 (55.38%) abnormal scans. Atrophy was the most common (72%) 
radiological finding in abnormal CT scans. No associations were found between 
current proposed CT guidelines in psychiatric patients with and without abnormal CT 
scans, although a history of previous traumatic brain injury (TBI) approached 
significance (p = .054). There was a significant correlation between abnormal CT 
scans and past or current substance use (X2 = 5.9508 P = .015). Abnormal CT 
findings increased with the Centers for Disease Control and Prevention (CDC) HIV 
immunological stage progression. The management of 9 patients changed; 7 of these 
CT scans were abnormal.   
 
Conclusion. In this study of CTB scans in HIV+ psychiatric inpatients, previously 
suggested criteria proposed in guidelines for imaging were not associated with 
abnormal CT findings. Current or previous substance use correlated with significant 
higher rates of abnormal CT findings. Due to the high yield of abnormal CT scans in 
this study, it is suggested that HIV+ psychiatric inpatients with previous or current 
substance use, a history of TBI or HIV immunological stages B or C, are considered 
for imaging as a priority. It is recommended that further studies with larger sample 
sizes, consisting of inpatient and outpatient populations, with control groups be 
conducted to investigate current or previous substance use as an indication in 
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ABBREVIATIONS 
 
AIDS – acquired immunodeficiency syndrome 
ARV – antiretroviral 
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CD4 - cluster of differentiation 4 
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CNS – central nervous system 
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CVA – cerebral vascular accident 
EBV – Epstein-Barr virus 
EEG – Electroencephalogram 
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FES – first episode psychosis  
GSH – Groote Schuur Hospital 
HAD – human immunodeficiency virus associated dementia 
HAND – HIV associated neurocognitive disease  
HIV – human immunodeficiency virus 
HIV-1 – human immunodeficiency virus type 1 
HIV-2 – human immunodeficiency virus type 2 
HIV+ - human immunodeficiency virus positive 
HSV – herpes simplex virus 
IHDS – International HIV dementia scale 
JCV – John Cunningham virus 
MRI – magnetic resonance imaging 
NHLS – National Health Laboratory Service 
OR – odds ratio 
PML – Progressive multifocal leukoencephalopathy  
RLS – resource-limited settings 
SA – South Africa 
SMI – serious mental illness 
TB – tuberculosis 
TBI – traumatic brain injury 
UCT – University of Cape Town 
VL – viral load 
 




Background and context 
Human immunodeficiency virus (HIV) emerged as a novel infection more than 35 
years ago. Southern Africa is currently the epicentre of the HIV global epidemic, with 
South Africa (SA) among the worst affected countries.[1] According to the latest mid-
year population estimates released by Statistics SA it is estimated that for 2016, 
12.7% of the total population is infected with HIV.  The total number of HIV infected 
persons in SA in 2016 is estimated at 7.03 million compared to the 4.02 million 
estimated in 2002. HIV is currently one of the 5 overall leading causes of death in SA. 
HIV was the leading cause of death in the Cape Winelands in the Western Cape 
according to stats SA’s 2013 report on mortality and causes of death in SA.[2] 
 
HIV can be staged according to clinical and/or immunological features. Clinical 
features are used to stage HIV into 3 main clinical stages: (1) primary HIV infection, 
(2) latent stage HIV/early symptomatic disease and (3) acquired immunodeficiency 
syndrome (AIDS). AIDS is defined as the development of specific AIDS related 
opportunistic infections or malignancies.3 Cluster of differentiation 4 (CD4) T-
lymphocyte count is used for immunological staging. A fall in CD4 T-lymphocytes is 
a hallmark feature of HIV infection. The CD4 count (measured in cells per microliter) 
predicts the development of opportunistic infections in HIV positive (HIV+) 
individuals. Immunological stages set out by the Centers for Disease Control and 
Prevention (CDC) are (1) category A, with a CD4 count of more than 500, (2) 
category B, with a CD4 count between 200-500 and (3) category C, with a CD4 count 
below 200. Immunological stages (category A, B and C) correspond to clinical stages 
(primary HIV, latent/early stage HIV and AIDS).[3,4] 
 
The brain is a major target in HIV infection. Cerebral spinal fluid (CSF) analysis has 
indicated that HIV enters the central nervous system (CNS) early in the course of the 
infection. HIV CNS pathogenesis occurs through two possible mechanisms, firstly 
direct invasion of the virus and secondly by activation of immune competent cells that 
result in damaging immunological processes within the CNS. CNS complications in 
HIV are estimated at 60-70%.[5] 
 
CNS abnormalities in HIV infection can be grouped under 3 main categories: (1) 
HIV-associated CNS lesions, (2) HIV-associated opportunistic infections and (3) 
HIV-associated neoplasms.[5] Common opportunistic infective agents in AIDS include 
toxoplasmosis, cryptococcus, herpes simplex virus (HSV), John Cunningham virus 
(JCV), cytomegalovirus (CMV), Epstein Barr virus (EBV) and mycobacterium 
tuberculosis (TB). TB caused by mycobacteria tuberculosis remains a significant 
threat to HIV+ individuals. [6,7] 
 
HIV infection causes a multitude of both neurological and psychiatric manifestations 
that can present along the entire disease trajectory. HIV and mental illness are 
responsible for a substantial proportion of the total burden of disease in developing 
countries especially in Sub-Saharan Africa. Mental illness and HIV/AIDS will both 
be in the top 10 causes of mortality and morbidity by the year 2020 as estimated by 
the Global Burden of Disease Survey.[8] 
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Mental illness and HIV/AIDS 
HIV+ patients are at an increased risk for mental illness. In general, psychiatric illness 
in HIV+ patients is associated with worse psychiatric and HIV outcomes. HIV-
associated neuropsychiatric disorders may result from organic brain disease, 
psychosocial factors or a combination of both. Advances in antiretroviral treatment 
are responsible for shifts in incidence and prevalence rates of HIV associated 
neuropsychiatric conditions. Neuropsychiatric conditions may occur at any stage of 
the disease.[8] 
 
Mood, anxiety and substance use disorder are common in HIV+ patients.  
Depressive disorders are the most common psychiatric manifestation in HIV+ 
patients. Prevalence rates of major depressive disorder of up to 50% have been 
reported. Unrecognised and untreated depression is associated with poor medication 
adherence and disease progression.[9] 
 
Psychosis in HIV+ patients can either be primary, secondary or a combination of 
both. Patients with a primary psychotic disorder are more likely to engage in high-risk 
behaviour and therefore are at an increased risk for contracting HIV.[9] 
 
Older HIV+ patients (>50 years) present with additional challenges. This group is 
more at risk of developing side effects from antiretroviral and psychotropic 
medication. The concept of accelerated aging through on-going increased 
inflammatory processes in this group has been proposed. Accelerated aging is 
associated with higher rates of psychiatric disorders.[10] 
 
HIV associated neurocognitive disorder (HAND) is characterised by progressive 
deterioration in neurocognitive functioning. The incidence of HAND has decreased 
but the prevalence is increasing worldwide due to highly affective antiretroviral 
(ARV) treatment. HAND was diagnosed in up to 23.5% patients attending HIV 
clinics in SA. Neurocognitive impairment is classified according to severity in (1) 
asymptomatic neurocognitive impairment, (2) mild neurocognitive impairment and 
(3) HIV associated dementia (HAD). Cognitive impairment can occur at any stage of 
HIV disease but generally symptomatic stages are associated with later stages of HIV 
disease.[6,11] 
 
Delirium is a syndrome often diagnosed in HIV+ psychiatric patients referred to 
psychiatry. More subtle forms of delirium can be present in HIV+ patients. These 
subtle presentations are often difficult to diagnose.[10] 
 
Neuroimaging in general psychiatry 
Severe mental disorders requiring in-patient care are costly to manage and specialized 
investigations like neuroimaging studies often form part of the diagnostic workup for 
psychiatric patients. The use of neuroimaging in psychiatry has increased over the last 
decade due to technological advances made in the field of imaging techniques. 
Imaging modalities are generally structural in nature, functional in nature or a 
combination of both. Three imaging modalities that are currently most used in the 
clinical setting are: CT, magnetic resonance imaging (MRI) and perfusion studies.[12] 
 
MRI images of the brain are of higher resolution compared to CT images. However, 
in clinical settings CT does provide some advantages over MRI: 
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• CT imaging is less expensive and more widely available 
• CT has fewer contraindications and greater accessibility.[12] 
 
Currently no clear concise guidelines exist for the use of CT scans in psychiatric 
settings. Several studies have attempted to generate guidelines for the use of imaging 
studies in psychiatric patients. These studies are however limited to the study 
population and generalisability of the findings remain a limitation. General guidelines 
common to these studies recommend the use of CTB in the following situations: (1) a 
history of head injury, neurological disease, stroke and dementia, (2) an abnormal 
neurological examination, (3) the presence of confusion or cognitive decline, (4) first 
onset psychosis or personality changes after the age of 50 years and (5) any atypical 
presentations.[13]  
 
Neuroimaging studies are also utilised to improve diagnostic accuracy in certain 
neuropsychiatric disorders by identifying specific affected brain areas and possible 
causes. Improved diagnostic accuracy is important in neuropsychiatric disorders like 
dementia and white matter disease. Neuroimaging studies may also be used to 
monitor disease progression.[5,12] 
 
A literature search was conducted on the proposed research topic. The aim of the 
search was to establish current knowledge on the study topic.  Various databases were 
searched using key words in different combinations. The following databases were 
used: PsychInfo, PubMed and Medline. Key words that were used: CT, computerised 
tomography, computed tomography, head, brain, neuroimaging, indications, 
guidelines, diagnostic, yield, HIV, human immunodeficiency virus, AIDS, acquired 
immunodeficiency syndrome, psychiatry, psychiatric, mental illness, mental disorder, 
atrophy, alcohol, illicit substances . A total of 267 articles were retrieved applying a 
filter for only human studies.  Title and abstracts were reviewed - articles most 
relevant to this research topic were selected – these articles are listed in the reference 
section. Studies that investigated CT in HIV populations were separated from studies 
investigating psychiatric populations – these studies are tabled in Table 1 and Table 2. 
 
CT yield in general psychiatry 
The yield of abnormal CTB scans in psychiatric patients is highly variable. Three 
previous studies reported abnormal CTB at 6.8%, 35% and 49.8% respectively.[13,14,15]  
Several factors contribute to the variability of abnormal CTB findings, including 
selection bias and differences in study populations. Brain atrophy is a common shared 
finding amongst these and other studies that investigated CTB scans in a psychiatric 
population.[13,14,15,16] 
 
Various studies have been conducted to investigate different aspects of imaging in 
psychiatric patients. These studies often focussed on first episode psychosis (FES) 
and the value of routine CTB scans as part of the initial workup. Agzarian (2006) 
investigated the use of routine computerised tomography brain scanning of psychiatry 
patients. This prospective study excluded psychiatric patients with focal neurological 
signs. In this study 20 out of a total of 397 or 5% of CTB scans were abnormal. The 
lower yield of abnormal CTB scans in this study population is most likely attributed 
to the exclusion of patients with focal neurological signs.[17] 
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Bain (1998) conducted a retrospective study at a military hospital. CTB scans of 
patients with FES and good general health were analysed. In this retrospective study 
123 out of 127 CTB scans were normal with 4 incidental findings. The study 
concluded that routine CTB scans for index psychosis may not be justifiable.[18] 
Battalgia (1988) had a similar finding from their prospective study on psychiatric 
inpatients with FES.[18] In contrast, Gewirtz (1994) supported FES as an indication for 
ordering CTB scans. In this cohort study 168 CTB scans were performed. Diffuse 
atrophy was found in 40% of all scans and other abnormalities in 6.6%.[20] 
 
An explorative study done by Jeenah (2007) investigated CTB scans at Chris Hani 
Baragwanath hospital in South Africa. All mentally ill inpatients age 18 years and 
older admitted during the study period were eligible for CT scans. Inclusion criteria 
were (i) first episode psychosis, (ii) psychotic patients with features of delirium, focal 
physical or neurological signs and/or (iii) abnormal special investigations.  A total of 
20 out of 55 or 36% of CTB scans were abnormal.[21] 
 
Larson (1981) conducted a retrospective study to determine the diagnostic yield of 
CTB scans in patients with psychiatric illness.  This study investigated the findings of 
a group of consecutive patients referred for CTB scans with a psychiatric illness. In 
their study 6 out of 123 CTB scans were assessed as a true positive finding suggesting 
that a ‘rule in approach’ based on the presence of focal neurological signs may 
increase the diagnostic yield of CTB scans.[22] 
 
In a retrospective study on CT and MRI scans in first presentation to psychiatric 
inpatient and outpatient services, Mueller (2006) reviewed 280 CTB scans of which 
161 CTB scans were normal, 52 abnormal and 67 equivocal. Focal neurological signs 
and advanced age were associated with higher abnormal imaging studies. This study 
highlighted the need for clear indications for neuroimaging studies in psychiatric 
inpatients.[23] 
 
Ananth (1993) signified the importance of clinical findings to guide the use of CTB 
scans in order to clarify or compliment findings in psychiatric patients. This 
prospective study randomised hospitalised psychiatric patients to investigate the 
clinical use of CTB scans. A total of 34 CTB scans were performed of which 9 were 
abnormal.[24] 
 
Two separate studies concluded that specific risk factors could be used as guidance in 
ordering CTB scans in psychiatric patients. Moles (1998) conducted a prospective 
study on psychiatric inpatients to identify clinical factors associated with increased 
CTB abnormalities. This study reported 53% of 150 CTB as abnormal. Organic 
mental syndromes and advanced age (60 years and above) were associated with 
higher abnormal CTB scans.[25] In a retrospective study by Hollister (1991) reviewing 
140 CTB scans over a 3-year period, several suggested indications for ordering CTB 
scans in psychiatric patients were identified; (i) History of head injury, stroke, 
neurological disease, (ii) presence of abnormal neurological signs or organic mental 
signs, (iii) first psychotic break or personality change after age 50 years.[13] 
 
In summary, CTB is used to exclude organic pathology in patients presenting to 
psychiatry. CT is the primary neuroimaging study available in resource limited 
settings. Clear guidelines for the use of CTB in psychiatric populations are still 
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lacking. Current suggested indications for CTB in psychiatric patients are derived 
from studies where generalisability is limited to those study populations. Table 1 
provides a summary of the findings from the various studies that investigated CTB 
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Table 1: A summary of previous studies investigating CT in psychiatric patients  
 
Study reference Study setting CT findings Conclusion 
Larson EB, Mack LA, Watts B, 
Cromwell LD. Computed tomography 
in patients with psychiatric illnesses: 
advantage of a ‘rule in’ approach. Ann 
Intern Med 1981;95(3):360-364. 
 
Retrospective study to determine the 
diagnostic yield of CTB scans in 
patients with a psychiatric illness. 
123 CTB scans 
performed. 
62 (50%) normal CTB 
scans. 
43 (35%) CTB scans 
with atrophy. 
6 (5%) true positive 
CTB scans. 
Ordering of CTB scans as a “rule in 
approach” based on the presence of 
focal neurological signs would be 
less expensive and more effective. 
 
Battalion J, Spector IC. Utility of the 





Prospective study on psychiatric 
inpatients admitted for FES. 
 
45 CTB scans 
performed. 
42 (93%) normal 
CTB. 
3 (7%) abnormal 
CTB. 
 
CTB scans for FES should be based 




Hollister LE, Boutros N. Clinical use of 
CT and MR scans in psychiatric 




Retrospective study reviewing 
neuroimaging studies requested at a 
psychiatric hospital over a 3-year 
period. 
 
Total of 140 CTB 
scans performed. 
78 (56%) normal CTB 
scans. 
4 (3%) equivocal CTB 
scans. 




Suggested indications for ordering 
CTB scans in psychiatric patients: 
(i) History of head injury, stroke, 
neurological disease, (ii) presence 
of abnormal neurological signs or 
organic mental signs, (iii) first 
psychotic break or personality 
change after age 50 years. 
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Study reference Study setting CT findings Conclusion 
Ananth J, Gamal R, Miller M, Wohl M, 
Vandewater S. Is the routine CT head 
scan justified for psychiatric patients? 
A prospective study. J Psychiatry 
Neurosci 1993;18(2):69-73. 
 
Prospective study of randomized 
hospitalised psychiatric patients to 
investigate the clinical use of CTB 
head scans. 
34 CTB scans 
performed. 
9 (26%) abnormal 
CTB scans. 
Clinical findings should guide the 
use of CTB scans to clarify or 
compliment the findings. 
Gewirtz G, Squires-Wheeler E, Sharif 
Z, Honer WG. Results of computerised 
tomography during first admission for 
psychosis. Br J Psychiatry 
1994;50:789-795. 
 
Cohort study of 168 patients that 
underwent CTB scans on first 
admission. 
168 CTB scans 
performed. 
Diffuse atrophy found 
in 40% of scans. 
Abnormalities other 
that atrophy found in 
6.6% 
 
Study supporting CTB scans for 
first onset psychosis. 
Bain BK. CT scans of first-break 
psychotic patients in good general 
health. Psychiatr Serv1998;49:234–235. 
Retrospective study on psychiatric 
patients evaluated for a psychotic 
illness at a military hospital that 
received a CTB scan. 
127 CTB scans 
performed. 
123 (97%) normal 
CTB. 
4 (35%) incidental 
findings. 
 
Study supports the finding that 
CTB scans for all newly psychotic 
patients may not be justifiable.  
Moles JK, Franchina JJ, Sforza PP. 
Increasing the clinical yield of 
computerized tomography for 
psychiatric patients. Gen Hosp 
Psychiatry 1998;20(5):282-291. 
 
A prospective study on psychiatric 
inpatients to identify clinical factors 
associated with increased CT 
abnormalities. 
150 CTB scans 
performed. 






Specific clinical risk factors can be 
used as guidance in ordering CTB 
scans in psychiatric patients to 
increase the yield. 
The incidence of abnormal CTB 
scans is increased in patients over 
60 years and in organic mental 
syndromes. 
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Study reference Study setting CT findings Conclusion 
Agzarian  MJ, Chryssidis S, Davies 
CH, Pozza CH. Use of routine 
computed tomography brain scanning 
of psychiatry patients. Australas radiol 
2006;50(1):27-28. 
 
To evaluate the usefulness of CTB in 
psychiatric conditions without focal 
neurological signs. Prospective study 
on psychiatric inpatient and 
outpatients referred for CT scans. 
397 CTB performed. 
337 (95%) normal 
CTB. 
20 (5%) abnormal 
CTB. 
Probability of finding lesions in 
psychiatric patients is not greater 
than for the general population. 
Mueller C, Rufer M, Moergeli H, 
Bridler R. Brain imaging in psychiatry 
– a study of 435 psychiatric in-patients 
at a university clinic. Acta Psychiatr 
Scand 2006,114(2):91-100.  
Retrospective study on CT and MRI 
head scans performed on first 
presentation to psychiatric inpatient 
and outpatient services.  
 
280 CTB scans 
performed.  
161 (57.5%) normal 
CTB scans. 
52 (18.5%) abnormal 
CTB scans. 
67 (24%) equivocal 
scans. 
 
The need exists for clear 
indications for neuroimaging 
studies in psychiatric inpatients. 
Focal neurological signs and 
advanced age are associated with 
increased abnormal imaging 
studies. 
Jeenah FY, Moosa MYH. CT scans in 
psychiatric patients - An exploratory 
study at Chris Hani Baragwanath 
Hospital. S Afr J Psychiatr 
2007;13(1):22-25. 
 
Prospective explorative study to 
determine the CT brain yield on 
psychotic inpatients. 
55 CTB scans 
performed. 
20 (36%) abnormal 
CTB scans. 
35 (64%) normal CTB 
scans. 
Psychiatric patients have a larger 
incidence of CTB abnormalities 
especially FES. Clinical 
abnormalities may not be a reliable 
predictor for abnormal CTB scans. 
  15 
CT brain yield in HIV 
CTB is a valuable tool used in the evaluation of HIV+ patients. Despite extensive 
research on CT abnormalities in HIV+ patients, clear guidelines for the use of CTB 
scans in this population are also lacking.[26] 
CTB scan findings in HIV+ patients often correspond to the level of 
immunosuppression. Opportunistic infections are more common in those patients with 
a CD4 of less than 200. Specific CTB findings are often useful in the diagnosis of the 
type of opportunistic infection.[7,27]  
Cerebral atrophy is also a common finding in CTB scans of HIV+ patients. Atrophy 
in tissue implies the loss of cells. The national institute of neurological disorders and 
stroke defines brain atrophy as a loss of neurons and the connections between 
them.[34] Brain atrophy can be generalised (affecting the whole brain) or focal 
(affecting only specific areas). Brain atrophy can be visualised on CTB scans by 
increased ventricular size and widening of sulci with diminished grey matter size. 
Atrophy in HIV is nonspecific and thus cannot currently be differentiated from other 
causes of atrophy, such as herpes encephalitis.[7] In a study conducted by Pfefferbaum  
(2012) investigating the effects of AIDS, alcohol and age in HIV infection, advanced 
CDC HIV staging revealed higher cerebral volume deficits in the HIV only group. 
Atrophy was also found to be related to several HIV-related factors including CD4 
cell-count nadir and a history of an AIDS-defining event.[28]  
 
CTB scans are often part of the initial diagnostic workup in HIV+ patients who 
present to psychiatry.[3] The shift of HIV to a chronic illness means that more 
neuroimaging studies, like CTB scans, will be performed in the future as part of the 
chronic management plan of these patients.[29] 
 
A study by Seth (1991) investigated all HIV/AIDS patients with a psychiatric illness 
referred to liaison psychiatry. A total of 23 CTB scans were ordered of which 17 or 
73.9% were abnormal. In this study patients that progressed to AIDS were 5 times 
more likely to be referred to liaison psychiatry services. Study findings also indicated 
a high diagnostic yield of CTB abnormalities in HIV+/AIDS psychiatric patients.[30] 
 
Hongsakul (2008) investigated findings of CTB scans in HIV+ homosexual men.  A 
randomly selected sample from a cohort of HIV+ homosexual men was selected and 
195 CT scans were performed. HIV encephalopathy was the most common brain 
finding affecting 59% of the study population. Toxoplasmosis was the most common 
opportunistic infection affecting 22%. Other CT findings were cryptococcoma (9%), 
tuberculous meningitis (5%), tuberculoma (4%), progressive multifocal 
leukoencephalopathy (PML) (3%) and lymphoma (2%).[31]  This study reflects the 
high incidence of abnormal CT findings in HIV+ patients. 
 
Mundinger (1992) investigated the use of CTB and MRI scans as a prognostic tool in 
patients with AIDS and neurological deficit.  Imaging studies of AIDS patients with 
only focal brain lesions and/or atrophy were reviewed. The study concluded that the 
mean survival time of patients with initial normal imaging studies were higher than 
those with initial abnormal imaging studies. Patients with both focal brain lesions and 
atrophy had the shortest survival time. The risk of death in these patients was 19.3 
times higher compared to patients with normal initial neuroimaging studies. This 
  16 
study proposed that CTB and MRI scans could be used to identify AIDS related brain 
pathology that may assist in AIDS prognosis.[32] 
 
Robert (1986) reviewed 200 consecutive AIDS patients with CTB scans. The study 
population consisted of homosexual men with AIDS and neurological symptoms 
ranging in age from 23 to 60 years. 81 of the 200 CTB scans were normal, 75 had 
atrophy and 44 had a focal lesion. The study findings suggested that MRI might be a 
valuable supplement to CTB in patients with generalised atrophy as MRI may reveal 
lesions not seen on CBT scans.[33] 
 
In summary, CTB is an invaluable tool in the diagnostic workup of HIV+ patients in 
resource limited settings. Toxoplasmosis is the most common opportunistic infections 
identified on CT in HIV+ populations. Atrophy is a common nonspecific finding with 
possible prognostic implications. 
Table 2 provide a summary of these studies. [27,31,32] 
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Table 2:  Previous studies investigating CT yield and clinical correlates in HIV+ patients 
 
Study reference Study setting CT findings Conclusion 
Robert M, Rosenbloom S, Perrett 
LV. Neuroradiological findings in 
AIDS: A review of 200 cases. 




of 200 consecutive 
homosexual men with 
AIDS and neurological 
symptoms were reviewed. 
200 CTB scans reviewed. 
81 (41%) normal CTB scans. 
75 (38%) CTB scans indicating atrophy. 
44 (22%) CTB scans with focal lesions. 
The study indicated that 
patients with AIDS might 
have normal CTB scans. 
AIDS patients with 
evidence of diffuse cerebral 
atrophy are more likely to 
progress both neurological 
and radiological. 
 
Seth R, Granville-Grossman K, 
Goldmeier S, Lynch S. Psychiatric 
illnesses in patients with HIV 
infection and AIDS referred to the 
liaison psychiatrist. Br J Psychiatry 
1991;159:347-350. 
 
Psychiatric illness in 
HIV/AIDS patients 
referred to liaison 
psychiatric in- and 
outpatient services. 
23 CTB scans performed. 
17 (74%) abnormal CT scans. 
6 (26%) normal CTB scans. 
11 (48%) CTB scans indicated atrophy. 
4 (17%) CTB scans with PML. 
The proportion of AIDS 
patients referred to liaison 
psychiatry was 5 times more 
than HIV+ patients. 
Mundinger A, Adam T, Ott D, 
Dinkel E, Beck A, Peter HH, Volk 
B. CT and MRI: prognostic tools in 
patients with AIDS and 
neurological deficits. 
Neuroradiology 1992;35(1):75-78. 
To determine if CT and 
MRI are of better 
prognostic value than 
clinical status in AIDS 
patients with neurological 
signs. Imaging studies of 
AIDS patients with only 
focal lesions and/or 
atrophy were reviewed. 
26 CTB scans performed. 
 
Mean survival time of 
patients with initial normal 
imaging studies was higher 
than that of patients with 
isolated focal lesions or 
atrophy. Atrophy with focal 
lesions correlates with the 
shortest mean survival time. 
CT and MRI scans allow 
identification of brain 
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Study reference Study setting CT findings Conclusion 
changes that may be of 
prognostic value. 
 
Hongsakul K,  Laothamatas . 
Computer tomographic findings of 
the brain in HIV+ patients at 
Ramathibodi Hospital. J Med 
Assoc Thai 2008; 91(6):895-907. 
Randomly selected sample 
from a cohort study of 
HIV+ homosexual men to 
evaluate the accuracy of 
CTB lesions. 
195 CTB scans performed. 
59% were HIV encephalopathy, 22% 
toxoplasmosis, 9% cryptococcoma, 5% 
tuberculous meningitis, 4% tuberculoma, 
3% PML, 2% lymphoma, and 1% normal. In 
non-specified causes (from CTB scan), 33% 
were meningitis, 4% cerebritis, and 5% 
infarction. 
HIV encephalopathy is the 
most common brain finding 
in HIV. Toxoplasmosis is 
the most common 
opportunistic infection. 
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AIMS AND OBJECTIVES 
 
Study aims 
The aim of the study was to determine the diagnostic yield of abnormal CTB scans in HIV+ 





1) To determine the yield of abnormal CTB scans in HIV+ psychiatric patients, 
2) To describe these abnormalities. 
3) To describe demographic and clinical variables associated with an abnormal CTB 





A retrospective exploratory folder review. 
 
Study setting 
The study was conducted in the department of Psychiatry at Groote Schuur Hospital in Cape 
Town, Western Cape.  Groote Schuur Hospital (GSH) is an academic teaching hospital 
affiliated to the University of Cape Town (UCT). 
 
Study population and sampling 
The study investigated all psychiatric inpatients, confirmed to be HIV+, who received one or 
more CTB scans during the study period (1st January 2013 to 30st June 2015). 
Psychiatric inpatients comprised of inpatients from either male or female acute units, 
neuropsychiatric and liaison-therapeutic units. Current suggested guidelines for CTB scans in 
psychiatric patients serve as a guide for ordering CTB in these units. 
 
Inclusion criteria: 
1. Male and female psychiatric inpatients, 
2. above 18 years of age, 
3. who presented at Groote Schuur Hospital 
4. during the study period (1st January 2013 to 30st June 2015).  
5. Confirmed HIV seropositive by laboratory HIV enzyme-linked immunosorbent assay 
(ELISA) or detectable HIV viral load. 
6. Patients who received one or more CTB scan (contrasted or uncontrasted) at or during 
their admission within the study period.  
 
Exclusion criteria: 
1. Patients below 18 years, 
2. CTB scans performed outside of Groote Schuur Hospital. 
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Sample size 
The sample consisted of all psychiatric inpatients who met the inclusion and exclusion 
criteria. The total sample size was 65. 
 
Study procedures 
All final CTB scan reports were reviewed by qualified radiologists.  
 
Medical records and radiological reports of all patients who met the inclusion and exclusion 
criteria were obtained and reviewed in detail. Referral documents, admission notes, progress 
notes, prescriptions, order instructions and discharge reports were reviewed from medical 
records.  Electronic entries and reports, obtained from patient databases through intranet 
access within GSH was also reviewed to subtract any relevant information. The three 
electronic databases that was used were Clinicom, National Health Laboratory Service 
(NHLS) and Isite. Relevant data was grouped under the following categories: 
• Demographical data and history 
• Clinical data 
• Radiological data 
• Other special investigations 
  
Data for each patient was captured on pre coded data capturing sheets. (Copy included in 
appendix) 
 
Demographic data and history: 
• Demographic data was collected on age, gender, relationship status and ethnicity.  
• Any significant history of current or previous alcohol or illicit substance use was 
recorded. Significant substance use included any recorded entries on substance use 
that were deemed to be excessive or problematic at the time the entry was made. 
• A history of seizure activity, traumatic brain injury (TBI) and cerebral vascular 
accidents (CVA) was recorded.  
• All index presentations to psychiatry was recorded. 
 
Clinical data: 
Relevant clinical data that was extracted: 
• Clinical data on presenting psychiatric symptoms before CTB scans. Presenting 
psychiatric symptoms were grouped as affective (mood) symptoms, psychotic 
symptoms, anxiety and post-traumatic symptoms, cognitive symptoms and other 
symptoms. A cluster approach was used to group psychiatric symptom presentation in 
clusters. 
Cognitive testing and screening tests for HIV associated dementia with scores were recorded. 
The Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) 
are two commonly used validated tests performed to assess cognitive functioning. The 
international HIV dementia scale (IHDS) is a validated rapid screening test for HIV 
associated dementia. [11]  Studies by Joska (2011) and Goodkin (2014) investigated the 
validity of the IHDS in a South African population. These studies however suggested adding 
brief tests of executive functioning and increasing the cut-off score of the IHDS respectively. 
[35,36] 
 
Education and cultural factors including language influence MMSE and MoCA scores. Score 
adjustments are made based on level of education however, limited information is available 
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on allowances made when scoring tests performed in a language other than the first language. 
[11]  
• Pharmacological treatment at the time of CTB scans.  
• Date of confirmed HIV status (confirmation by HIV ELISA or detectable HIV viral 
load), initiation of ARVs, HIV treatment failure, and compliance with ARVs and 
immunological stages at the time of CTB scan were recorded. 
• The presence of any focal neurological findings on the neurological examination 
before the CTB scans. An abnormal neurological examination was defined as any 
abnormality or deficit in cranial nerve, motor, sensory or reflexes function. 
• Other comorbid medical conditions at the time of the scan (excluding psychiatric 
conditions or HIV infection).  
• Any complications as a direct result of CTB scans performed.  
 
Other special clinical investigations: 
• Most recent CD4 count and viral load before the CT scan. 
• CSF findings.  
• Electroencephalogram (EEG) findings. 
 
Radiological findings: 
The final CT brain report for the 1st CTB scan performed on or during admission for each 
patient within the study period was reviewed to extract relevant data: 
• The department that requested the initial CTB scan during the study period. 
• Indications for CTB scans.  
• CTB scan findings were recorded as normal (negative) or abnormal (positive) and 
contrasted or uncontrasted. A positive finding was regarded as abnormal intracranial 
findings noted on CTB reports. The presence of any atrophy on CTB scans was 
regarded as a positive finding. Different methods have been proposed to quantify 
atrophy. These methods however are not commonly used in clinical settings 
especially with lower resolution CT imaging.  
 
Medical records of all patients with an abnormal CTB scan reports within the study period 
were reviewed for 2 weeks for any change in management following the date of the CTB 
scan report. A change in management was defined as any change in the diagnosis, treatment 
or prognosis as a result of the CTB scan report. Changes in management included any special 
orders or additional special investigations ordered after the CTB scan was performed as a 




The diagnostic yield of CTB scans in HIV+ psychiatric patients in this population was 
unknown. No study known to the research team has been done in SA that investigated CT 
scans specifically in HIV+ psychiatric patients.  Also, no clear guidelines exist to help 
identify those patients with HIV and mental illness who will benefit most from CTB scans in 
a resource-limited setting. In order to address this gap, we aimed to determine the yield of 
abnormal CTB scans in HIV+ psychiatric patients and to describe these abnormalities 
including demographic and clinical variables associated with an abnormal CTB scan.
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Background. HIV infection increases the risk for mental illness. Neuroimaging is an 
important part of the diagnostic workup in HIV+ psychiatric patients; CT is the primary 
neuroimaging modality available in resource limited settings. Despite advances in 
neuroimaging no clear guidelines exist for the use of CT in psychiatric settings. 
 
Objective. To determine the diagnostic yield of CT brain (CTB) scans in HIV+ psychiatric 
patients and to describe these abnormalities as well as demographic and clinical variables 
associated with abnormal CT scans. 
 
Methods. A retrospective study was conducted at the Department of Psychiatry and Mental 
illness at Groote Schuur Hospital, Cape Town, South Africa. Clinical and radiological data 
for HIV+ psychiatric patients who received a CTB scan during admission were analysed for 
the period January 2013 – June 2015. 
 
Results. A total of 65 patients met the inclusion criteria. The mean age of the participants in 
this study was 36.2 years (range 18 – 64). The most common presenting psychiatric 
symptoms were psychosis (81.54%), cognitive deficits (72.41%) and mood symptoms 
(69.23%). CT scans results consisted of 29 (44.62%) normal scans and 36 (55.38%) abnormal 
scans. Atrophy was the most common (72%) radiological finding in abnormal CT scans. No 
associations were found between current proposed CT guidelines in psychiatric patients, 
although a history of previous traumatic brain injury (TBI) approached significance (p = 
0.054). There was a significant correlation between abnormal CT scans and past or current 
substance use (X2 = 5.9508 P = .015). Abnormal CT findings increased with the Centers for 
Disease Control and Prevention (CDC) HIV immunological stage progression. The 
management of 9 patients changed; 7 of these CT scans were abnormal.   
 
Conclusion. In this study of CTB scans in HIV+ psychiatric inpatients, previously suggested 
criteria proposed in guidelines for imaging were not associated with significantly higher rates 
of abnormal CT findings. Current or previous substance use correlated with significant higher 
rates of abnormal CT findings. Due to the high yield of abnormal CT scans in this study, it is 
suggested that HIV+ psychiatric inpatients with previous or current substance use, a history 
of TBI or HIV immunological stages B or C, are considered for imaging. It is recommended 
that further studies with larger sample sizes, consisting of inpatient and outpatient 
populations, with control groups be conducted to investigate current or previous substance 
use as an indication in guidelines for CTB scan in HIV+ psychiatric patients. 
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INTRODUCTION 
 
The impact of the human immunodeficiency virus (HIV) pandemic on world-wide health 
care systems is substantial with resource-limited settings (RLS) most affected. South Africa 
(SA) is located at the epicentre of the pandemic, with 12.7% of total population in 2016 
infected with HIV.[1]  
 
HIV positive (HIV+) patients are at an increased risk for mental illness. The brain is a target 
of HIV infection early on in the disease and neuropsychiatric disorders may occur at any 
stage of the disease. Neuroimaging investigations are often part of the diagnostic workup in 
HIV.[2] The shift of HIV to a chronic illness also means that more neuroimaging 
investigations, such as CT scans, will be performed in the future as part of the management 
plan of these patients.[3] Computerised tomography (CT) and magnetic resonance imaging 
(MRI) are structural neuroimaging modalities most often used in clinical settings. MRI is 
regarded as the neuroimaging modality of choice as it produces higher resolution images, 
especially of the sub-cortex. However, in RLS, CT does provide some advantages over MRI 
as it is less expensive, is more widely available and has fewer contraindications.[4]  Despite 
the availability of CT, it remains a restricted resource, and it is not clear whether every 
patient with HIV and a serious mental illness (SMI) requires a CT brain (CTB) scan. 
 
No clear guidelines exist for the use of CTB scans in psychiatric inpatient and outpatient 
populations. Several studies have attempted to generate guidelines for the use of imaging 
studies in psychiatric populations: Generally, studies recommend CTB scans for patients with 
(i) a history of head injury, (ii) abnormal neurological examination, (iii) the presence of 
confusion or cognitive decline, (iv) first onset psychosis or personality change after the age of 
50 years and (v) any atypical presentation.[5] These studies are however limited to the 
respective study populations reported on and therefore generalisability remains a limitation. 
The yield of abnormal CTB scans in psychiatric patients is also highly variable, ranging from 
7% to 53%[6,7]. Factors contributing to the variability including selection bias, differences in 
defining CTB abnormalities and unique differences in study populations. 
 
Groote Schuur Hospital is a tertiary hospital in the Western Cape in a RLS. CT is the primary 
neuroimaging modality as access to MRI remains restricted. No clear guidelines are available 
as to which HIV+ psychiatric patients will benefit most from CTB scans. As many patients 
with both HIV and psychiatric disorder are seen and managed, a targeted approach to 
requesting CTB is desirable, in order to set priorities and plan investigations during 
admission (i.e. urgent vs non-urgent scans). This study was conducted to provide information 
on the current CTB scan yield of HIV+ psychiatric patients as an essential initial step for 
guideline development in this sub-population.  
 
In order to address this gap, we aimed to explore the following (i) to determine the yield of 
abnormal CTB scans in HIV+ psychiatric patients, (ii) to describe these abnormalities and 
(iii) to describe demographic and clinical variables associated with an abnormal CTB scan in 
HIV+ patients with a psychiatric disorder.  
 
 





A retrospective folder review was conducted in the clinical Department of Psychiatry and 
Mental Health at Groote Schuur Hospital (GSH) in Cape Town.  GSH is an academic 
teaching hospital affiliated to the University of Cape Town (UCT). The department provides 
services at secondary and tertiary level, including service at the Emergency Unit, as well as 
neuropsychiatric and liaison-therapeutic admissions. The study was approved by the Human 
Research Ethics committee (HREC) of the UCT. 
 
Criteria for eligibility 
The study investigated all psychiatric inpatients, confirmed to be HIV+, who received a CTB 
scan during the study period January 2013 to June 2015. Inclusion criteria were: (i) male and 
female psychiatric inpatients, (ii) above 18 years of age, (iii) who presented at GSH, (iv) 
during the study period, (v) confirmed HIV seropositive by laboratory HIV enzyme-linked 
immunosorbent assay (ELISA) or detectable HIV viral load, (vi) who received one or more 
CTB scan (contrasted or uncontrasted) at or during their admission within the study period. 
Exclusion criteria were: (i) patients below 18 years, (ii) CTB scans performed outside of 
GSH and (iii) HIV status not confirmed by laboratory HIV ELISA or HIV viral load. 
 
Study Procedures 
Medical records and radiological reports of all patients that met the inclusion an exclusion 
criteria were obtained and reviewed. Data were grouped as: (i) demographic data and history, 
(ii) clinical data, (iii) other special investigations, (iii) radiological data and (iv) a change in 
management. Psychiatric symptoms were grouped into clusters of affective (mood), 
psychotic, anxiety, post-traumatic, cognitive and other psychiatric symptoms. The Mini 
Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) and The 
International HIV Dementia Scale (IHDS) scores were recorded as evidence for cognitive 
impairment. The final CTB report for the first CTB scan performed for each patient was 
reviewed. The validity of these scales in a South African population have been investigated in  
studies by Joska (2011) and Goodkin (2014). [8,9] CTB scan findings were recorded as normal 
(negative) or abnormal (positive). The presence of atrophy on CTB scans was regarded as a 
positive finding. Different methods have been proposed to quantify atrophy, however these 
methods are not commonly used in clinical settings especially with lower resolution CT 
imaging. Cluster of differentiation 4 (CD4) T-lymphocyte count was used for immunological 
staging. Immunological stages set out by the Centers for Disease Control and Prevention 
(CDC) are (1) category A, with a CD4 count of more than 500, (2) category B, with a CD4 
count between 200-500 and (3) category C, with a CD4 count below 200.[10] Medical records 
of all patients with abnormal CTB scan reports were reviewed for a change in management. 
A change in management was defined as any change in the diagnosis, treatment or prognosis 
as a result of the CTB scan report.  
 
Statistical analysis 
We calculated percentages, minimum and maximum values, 95% confidence intervals, 
medians and means including standard deviations. The Chi-square test was used to explore 
differences between categories of abnormal and normal CTB scans. The association between 
categorical characteristics of the group with normal CTB scans and the group with abnormal 
CTB scans were determined using Pearson’s correlation co-efficient. Cramér's V was used to 
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measure the strength of association between variables. Data analysis was done using STATA 




During the 30-month study period, 65 patients met the study inclusion criteria of which 26 
(40%) were male and 39 (60%) female. Patients ranged in age from 19 to 64 years 
(mean=36.2; SD=10.4). The males were generally older: Nearly half of male patients 
(46.15%) were in the age category 31 – 40 years and very few (7.69%) in the age category 18 
– 30 years. In contrast, almost half (48.72%) of females were in the age category 18 – 30 
years and fewest (5.13%) in the age category 51 – 65 years. The study population consisted 
of 73.85% black, 16.92% coloured, 7.69% white and 1.54% and mixed race patients.  
The most common presenting psychiatric symptoms overall were psychosis (81.54%), 
cognitive deficits (72.41%) and mood symptoms (69.23%). In the study population 9 patients 
were newly diagnosed HIV+, 13 defaulted ARV treatment and 17 had a detectable viral load. 
CTB scan results consisted of 29 (44.62%) normal scans and 36 (55.38%) abnormal scans. 
Imaging findings 
More than half of CTB scans (55.38%) were reported as abnormal. Details of the abnormal 




Abnormal CTB findings 
Details Number (N) 
Atrophy 
Findings consistent with neurocysticercosis 
Encephalomalacia 
Nonspecific white matter lesions 







Nearly two thirds of male patients (61.54%) had abnormal scans- see Table 2. In the group 
with abnormal scans the gender distribution was similar, 18 (75%) had a history of current or 
previous substance use, 8 (53.33%) had a history of seizures, 7 (87.50%) had a history of 
traumatic brain injury (TBI) and for 16 (50%) patients, this was the index presentation to 
psychiatry. Details of the type of substance use, and substance use by age groups are 
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There was no significant difference between the abnormal and normal CTB scan groups with 
regard to a history of seizures, TBI or an index presentation to psychiatry. 
There was however a significant correlation between abnormal CT scans and past or current 
substance use (X2 = 5.9508 P = .015). Table 2 reflects demographic, clinical and disease 
variables, commonly listed as key variables supporting the need for CTB in general or HIV 
populations. Although the numbers of patients with a history of TBI was small, this 
characteristic approached significance (p = .054). 
 
Table 2 











   Gender 
      -male  
      -female 
   Ethnicity 
      -black 
      -coloured 
      -white 
      -mixed 
   Current or previous substance use 
   Current or past seizures 
   History of traumatic brain injury 
Current or past tuberculosis 
    -current 
    -past 
   Index presentation to psychiatry 
   Older than 50 years and index 





















































X2 = 0.6641  P = .415 
 
 





X2 = 5.9508  P = .015 
X2 = 0.5307  P = .466 
X2 = 3.7187 P = .054 
X2 = 1.7830  P = .410 
 
 
X2 = 0.7722  P = .380 
X2 = 0.6000  P = .439 
Clinical data:  
   Presenting psychiatric symptoms 
      -mood 
      -psychotic 
      -delirium 
      -other 
   Cognitive deficits 
   Focal neurological signs 
   Newly diagnosed HIV 

































X2 = 1.2608  P = .262 
X2 = 0.1727  P = .678 
X2 = 2.7447  P = .098 
X2 = 1.0045  P = .316 
X2 = 0.0009 P = .976 
X2 = 1.2183  P = .270 
X2 = 2.0557  P = .152 
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Table 2 
Characteristics of the study sample 
Other special investigations:         
   Immunological stage 
      -stage A 
      -stage B 
      -stage C 
   HIV viral load 
      -detectable 
      -lower than detectable 
   EEG 
      -normal 
      -abnormal 
   CSF 
      -normal 
      -abnormal 



















































X2 = 1.0860  P = .297 
 
 
X2 = 0.9105  P = .340 
 
 
X2 = 3.5609  P = .169 
 
There were no significant differences in the distribution of presenting psychiatric symptom 
clusters across normal and abnormal scan groups. There were higher proportions of patients 
with mood disorders (60 vs 40%) and cognitive deficits (61.90 vs 38.10%) but these were not 
significant. Of note, a higher number of patients with delirium had normally reported scans 
(80 vs 20%) but the numbers were very small. These proportions are shown in Figure 2. 
Focal neurological deficits were present in 6 patients of which only 2 (33.33%) had abnormal 
scans. Of the 9 newly diagnosed HIV+ patients, 3 (33.33%) had abnormal scans. The 





HIV disease characteristics 
Nearly half of patients (43.75%) with a known CD4 count were classified as stage B 
according to the CDC immunological classification of HIV. In the group with abnormal CTB 
scans 7 (19.44%) of the 36 with abnormal scans were classified stage A, 16 (44.44%) stage B 
and 13 (36.11%) stage C. The majority (61.90 vs 38,10%) of the stage C had abnormal CTB 
scans. Table 3 and Figure 3 set out the characteristics of the study sample associated with 
the HIV immunological stages. The proportion of normal scans decreased with disease stage 
progression. Of the female patients, there were more with stage B and stage C disease. More 
patients with an index presentation were in these later stages of disease and more patients 













































Figure 3 Normal and abnormal 
scans according to 
immunological stages
Normal Abnormal
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between index presentation to psychiatry and CDC HIV immunological stages (X2 = 9.1101 








Stage A Stage B Stage C Statistical analysis 
Gender 
    -male 
    -female 
Current or previous substance    
 use 
Index presentation to 
psychiatry 
Newly diagnosed HIV 
Defaulted ARVs 
Previous ARV treatment 
failure 
Presence of focal 
neurological   
 signs 
Tuberculosis 
    -current 










































































X2 = 5.5943 P =.061 
 
 
X2 = 0.7670 P = .681 
 
X2 = 9.1101 P = .011 
 
X2 = 0.6095 P = .737 
X2 = 0.1478 P = .929 
X2 = 5.5552 P = .062 
 
X2 = 3.1135 P = .211 
 
 
X2 = 9.0081 P = .061 
 
 
X2 = 1.8295  P = .767 
 
An equal distribution was found in the group with abnormal CTB scans with a detectable and 
a lower than detectable viral load. The majority (58.82%) of patients with a detectable viral 
load had abnormal CTB scans. Electroencephalograms (EEGs) were requested for 10 patients 
– and all were reported as being within normal limits. CSF analysis were done on 54 patients 
of which 16 (29.63%) had abnormal results. The majority of patients with abnormal CSF 
results (75%) had abnormal CTB scans. These differences, however, did not reach statistical 
significance. No significant difference was found between the abnormal and normal group 
with regard to data on special investigations (Table 2). 
 
Outcomes of imaging 
A total of 9 patients had a change in their management associated with the CTB scan 
findings. All except 1 of these CTB scans were abnormal. A brain MRI scan was requested 
for the patient with the normal CTB scan – the MRI was reported as normal. Details of the 
type the management change are listed in Table 4.  
 
Table 4 
Change in patient management associated with CTB findings 





Change in management as a direct result of CT 
scan findings 
Type of management change 
   -additional special investigations requested 
   -change in diagnosis 













X2 = 4.7456  P = .029 
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Table 5 compare the study results with current recommended guidelines advocating CTB 
scans in psychiatric patients. None of these variables were significant – a previous history of 
TBI approached significance level. 
 
Table 5 
Results according to current recommendations for CTB in psychiatric patients    
(N (%)) 







Previous significant traumatic brain injury 
Focal neurological signs 
Presence of cognitive decline 















X2 = 3.7187 P = .054 
X2 = 1.2183  P = .270 
X2 = 0.0009 P = .976 
X2 = 0.6000  P = .439 
 
DISCUSSION 
The overall yield of abnormal CTB scans in this study was high (55.38%). Atrophy was the 
most common (72%) radiological finding in abnormal CTB scans. A significant correlation 
was found between abnormal CTB scans and current or previous substance use. In this 
retrospective study, we did not find associations between proposed CTB guidelines in 
psychiatric patients, although a history of previous TBI neared significance.  
 
The high yield of abnormal CTB scans indicate that our study population should be 
considered at high risk for abnormal CTB scans. Other studies that investigated CTB in 
psychiatric patients had similar high yields at 35%, 53% and 49.8%.[6,11,12] The reason for the 
high yield is probably related to the sample taken from a tertiary hospital population. It is 
likely that the yield would be lower in non-inpatient samples and primary health care settings. 
In our study, as HIV immunological stage progressed abnormal CTB scans increased. 
Similarly, as HIV immunological stage progressed the psychiatric symptom cluster 
presentations increased. Therefore, in our study HIV immunological stage progression, CDC 
B and C, was associated with higher abnormal CTB scans and psychiatric symptom clusters 
presentation. 
 
Cerebral atrophy is a common finding in CTB scans of HIV+ patients.[13] In a study 
conducted by Pfefferbaum (2012) that investigated the effects of AIDS, alcohol and age in 
HIV infection, advanced  CDC HIV stages revealed higher cerebral volume deficits in the 
HIV only group.[18,19] In our study a higher proportion of atrophy was present in 
immunological stages B and C. The incidence of atrophy in our study (43.08%) was similar 
to previous studies. Previous studies investigating CTB findings in HIV+ populations found 
atrophy in 38% and 45% of CTB scans, while in general psychiatric populations atrophy has 
been reported in 35% and 40% of CTB scans respectively.[14,15,16,17] Both of these studies, in 
general psychiatric populations, were conducted in inpatient populations with first episode 
psychosis and other SMI requiring admission. In addition to the presence of SMI contributing 
to CT changes, neuroimaging studies have also reported structural brain changes associated 
with substance and alcohol use. Common findings include diffuse atrophy and nonspecific 
lesions.[19] Combinations of these factors in our population, including the high prevalence of 
substance use most likely explain why atrophy was the most common finding in abnormal 
CTB scans. 
 
  34 
A study conducted by Patel (2002) indicated that neurocognitive deficits significantly 
correlated with brain atrophy in a cohort of HIV+ and noninfected indiviuals. The study 
found that atrophy predicted a poor neuropsychological test score performed by using a 
standard battery of eight tests (NPZ-8 test battery).[20] Cognitive impairement in HIV+ 
individuals is a significant barrier to the management of risk behaviour and is associated with 
suboptimal adherence to treatment. The presence of brain atrophy must therefore be taken 
into account in the management of HIV+ psychiatric patients as adherence strategies should 
be stepped up to ensure adequate follow up and treatment adherence.[21] 
 
The small sample size probably limited our study from finding associations with previous 
suggested guidelines for CTB scans in psychiatric patients. A history of TBI is a salient 
finding on history taking and therefore one of the proposed indications for CTB scans in 
psychiatric patients likely to be recorded. This may account for the near significance finding 
despite our small sample size. 
 
Generalisability of this study is limited due to the focused population - consisting of a unique 
subset within a psychiatric population treated at a tertiary hospital. The majority of previous 
studies investigated the yield of CTB scans in general psychiatric populations and therefore 
comparing study results with other studies may not represent an accurate finding. The 
incidence of HIV associated opportunistic infections and other neurological disease entities in 
this study may not be a true reflection of the population incidence, as this group of patients 
are primarily referred to neurology for management. Finding statistically significant 
associations between groups was limited by the small sample size and therefore the measure 
of association between a history of substance use and atrophy could not established. 
Nonetheless, the study findings provide essential data on the population subset not previously 
know. 
 
Previous studies that investigated CTB in psychiatric patients were able to recruit higher 
sample sizes from general psychiatric populations, however limited data was generated on 
HIV within these populations. In our study we were able to generate data on HIV+ 
psychiatric patients, however the sample size was affected by narrowing the inclusion 
criteria. 
 
Our study results indicate that past or current substance use and a history of TBI increase the 
probability of abnormal CTB findings in HIV+ psychiatric inpatients.  
 
CONCLUSION 
In this study of CTB in HIV+ psychiatric inpatients, we note that previously suggested 
criteria proposed as a guideline for imaging were not associated with significantly higher 
rates of abnormal CTB findings, although the presence of previous TBI neared significance. 
We did find that current or previous substance use was associated with significant higher 
rates of abnormal CTB findings. Abnormal CTB findings increased with CDC HIV 
immunological stage progression. Atrophy was the most common finding in abnormal CTB 
scans. The data may be limited by the sample size due to the narrow inclusion criteria. Due to 
the high yield of abnormal CTB scans in this study, it is suggested that HIV+ psychiatric 
inpatients with previous or current substance use, a history of TBI or HIV immunological 
stages B or C, are considered for imaging as those with abnormal findings are highly likely to 
undergo a change in management.  
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It is recommended that further studies with larger sample sizes, consisting of inpatient and 
outpatient populations, with control groups be conducted to investigate current or previous 
substance use as a proposed indication for CTB scan in HIV+ psychiatric patients. 
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— /— /— 
DATE OF CT (dd/mm/yr) 
— /— /— 
CT FINDINGS NORMAL 
 
ABNORMAL 
14 DAYS POST 
CT 
(dd/mm/yr) 



















 [  ] 18-30 
[  ] 31-40 
[  ] 41-50 
[  ] 51-65 
[  ]  > 65 
HIGHEST LEVEL OF 
EDUCATION 
[  ] STANDARD 
      _________ 
[  ] GRADE 
     ______ 
[  ] OTHER 
     ______ 
[  ] NOT KNOWN 
 [  ] < GRADE 5 
[  ] GRADE 5 - 9 
[  ] GRADE 10 - 12 
[  ] > GRADE 12 
[  ] NOT KNOWN 
GENDER   [  ] MALE 
[  ] FEMALE 




[  ] SINGLE 
[  ] MARRIED 
[  ] DIVORCED 
[  ] WIDOWED 
[  ] NOT KNOWN 
  
[  ] SINGLE 
[  ] NON-SINGLE 
[  ] NOT KNOWN 
ETHNICITY   [  ] BLACK 
[  ] COLOURED 
[  ] WHITE  
[  ] ASIAN 
[  ] MIXED 
[  ] OTHER 
    _______ 




[  ] Yes 
[  ] No 
[  ] Not known 
 
ALCOHOL: 
[  ] Yes 
[  ] No 
[  ] Not known 



















[  ] Yes 
[  ] No 
[  ] Not known 
SEIZURE HISTORY   [  ] YES 
[  ] NO 




  [  ] YES 
[  ] NO 
[  ] NOT KNOWN 






  [  ] YES 
[  ] NO 




  [  ] YES 
[  ] NO 






(before date of CT) 
MOOD/AFFECTIVE: 
[  ] Depressive 
[  ] Dysthymic 
[  ] Hypomanic 
[  ] Manic 
[  ] Mixed 
 
PSYCHOTIC 
[  ] Thought                        
     disordered 
[  ] Delusions 
[  ] Perceptual   
     disturbances 
 
[  ] ANXIETY 
 
[  ] PTSD 
 
[  ] OCD 
 
[  ] COGNITIVE 
 
[  ] OTHER 






















[  ] MOOD/               
     AFFECTIVE 
 
[  ] PSYCHOTIC 
 
[  ] ANXIETY 
 
[  ] PTSD 
 
[  ] OCD 
 
[  ] COGNITIVE 
 





[  ] MMSE   __/__ 
    [  ] > 26 (normal) 
    [  ] 24 - 26 (mild  
        cognitive    
        impairment) 
    [  ]  < 24 (cognitive       
          impairment) 
 
[  ] MoCA  __/__ 
   [  ] 18-26 (mild   
        cognitive  
        impairment) 
   [  ] 10-17 (moderate   
        cognitive   
        impairment)  
   [  ] < 10 (severe   
       cognitive  
       impairment.  
  
[  ] IHDS  __/12 
     [  ] >10 (normal) 
     [  ]  10 or less   
           (positive) 
 NEUROCOGNITIVE 
DEFICITS 
[  ] Present 
[  ] Absent 
 





(on date of CT) 
ARVs 
[  ] Yes 
[  ] No 




[  ] Antidepressants 
[  ] Antipsychotics 
[  ] Anxiolytics 
[  ] Mood stabilisers 
     (including anti-   
     convulsants used for  
     mood stabilizing       
     properties) 
[  ] Other psychiatric 
 
OTHER  
[  ] Anti-convulsants  
    (used specifically for  
    seizure disorders) 























[  ] Yes 
[  ] No 
[  ] Not known 
 
PSYCHOTROPICS 
[  ] Yes 
[  ] No 
[  ] Not known 
  
HIV CONFIRMED DATE: 
(mm/yr) 
___/___ 
[  ] NOT KNOWN 
 
CONFIRMATION TEST: 
[  ] ELISA 
[  ] Viral load 
 
ARV START DATE 
(mm/yr) 
___/___ 
[  ] Not known 
 
COMPLIANT-ARVs 
[  ] Yes 
[  ] No 
[  ] Not known 
 
PREV ARV Rx FAILURE 
[  ] Yes 
[  ] No 
[  ] Not known 









[  ] A CD4 >500 
[  ] B CD4 200-500 
[  ] C CD4 < 200 
  
ARVs initiated  
[  ] < 6 week prior to  
   date of admission 
[  ] > 6 weeks prior to  
   date of admission 
[  ] not known 
 
COMPLIANT-ARVs 
[  ] Yes 
[  ] No 
[  ] Not known 
 
PREV ARV Rx FAILURE 
[  ] Yes 
[  ] No 
[  ] Not known 
 
IMMUNOLOGICAL STAGE 
[  ] Not known 
[  ] A 
[  ] B 
[  ] C 









[  ] Yes 
[  ] No 




[  ] Yes 
[  ] No 
[  ] Not known 
 
TB 
[  ] Yes 
[  ] No 
[  ] Not known 
 
OTHER 
[  ] Yes 
[  ] No 
[  ] Not known 




















[  ] Yes 
[  ] No 




[  ] Yes 
[  ] No 




  [  ] Yes 
[  ] No 
[  ] Not known 
PSYCHIATRIC 
DIAGNOSIS 























CHANGE IN DIAGNOSIS 
[  ] Yes 
[  ] No 
[  ] Not known 
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OTHER SPECIAL INVESTIGATIONS 





[  ] Not known 
 CD4 
[  ] < 200 
[  ] 200-500 
[  ] > 500 
[  ] Not known 
VIRAL LOAD 
(VL) 





[  ] Not known 
 VL 
[  ] Detectable 
[  ] Lower than detectable 






[  ] Done 
[  ] Not done 
[  ] Not recorded 













[  ] Normal 
[  ] Abnormal 






[  ] Done 
[  ] Not done 
[  ] Not known 










[  ] Normal 


























[  ] Psychiatry 
[  ] Emergency department 
[  ] Neurology 
[  ] Other 
     ___________________ 
 
[  ] CONTRASTED 
[  ] UNCONTRASTED 
 
ATROPHY 
[  ] No 
[  ] Yes   
    [  ] Age appropriate    
         atrophy 
    [  ] age inappropriate  
         atrophy 

























[  ] Normal 
[  ] Abnormal 
[  ] Inconclusive 
 
 
CHANGE IN MANAGEMENT 
DATE OF CT (dd/mm/yr) 
___/___/___ 
  





CHANGE IN MANAGEMENT 
 [  ] No 
 [  ] Yes 
     [  ] Diagnosis 
     [  ] Treatment 
     [  ] Prognosis 
     [  ] Special investigations 
     [  ] Special orders 
     [  ] Other 













Change in management 
[  ] Yes 
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author(s) for correction, which will delay publication. 
  
General: 
• Manuscripts must be written in UK English. 
• The manuscript must be in Microsoft Word or RTF document format. Text must be single-spaced, in 
12-point Times New Roman font, and contain no unnecessary formatting (such as text in boxes). 
• Please make your article concise, even if it is below the word limit. 
• Qualifications, full affiliation (department, school/faculty, institution, city, country) and contact details 
of ALL authors must be provided in the manuscript and in the online submission process. 
• Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 'intravenous (IV)' 
or 'Department of Health (DoH)'. 
• Scientific measurements must be expressed in SI units except: blood pressure (mmHg) and haemoglobin 
(g/dL). 
• Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
• Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' but '50%' and '19ºC'. 
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• Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b not B for beta, etc. 
• Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
• Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
• Round brackets (parentheses) should be used, as opposed to square brackets, which are reserved for 
denoting concentrations or insertions in direct quotes. 
• If you wish material to be in a box, simply indicate this in the text. You may use the table format –this is 
the only exception. Please DO NOT use fill, format lines and so on. 
  
SAMJ is a generalist medical journal, therefore for articles covering genetics, it is the responsibility of 
authors to apply the following: 
- Please ensure that all genes are in italics, and proteins/enzymes/hormones are not. 
- Ensure that all genes are presented in the correct case e.g. TP53 not Tp53. 
**NB: Copyeditors cannot be expected to pick up and correct errors wrt the above, although they will raise 
queries where concerned. 
- Define all genes, proteins and related shorthand terms at first mention, e.g. ‘188del11’ can be glossed as 
‘an 11 bp deletion at nucleotide 188.’ 
- Use the latest approved gene or protein symbol as appropriate: 
• Human Gene Mapping Workshop (HGMW): genetic notations and symbols 
• HUGO Gene Nomenclature Committee: approved gene symbols and nomenclature 
• OMIM: Online Mendelian Inheritance in Man (MIM) nomenclature and instructions 
• Bennet et al. Standardized human pedigree nomenclature: Update and assessment of the 
recommendations of the National Society of Genetic Counselors. J Genet Counsel 2008;17:424-
433: standard human pedigree nomenclature. 




• In Practice and Case reports 
• Reviews 
• Clinical trials 
• Correspondence 
• Obituaries 




Guideline word limit: 4 000 words 
  
Research articles describe the background, methods, results and conclusions of an original research study. 
The article should contain the following sections: introduction, methods, results, discussion and 
conclusion, and should include a structured abstract (see below). The introduction should be concise – no 
more than three paragraphs – on the background to the research question, and must include references to 
other relevant published studies that clearly lay out the rationale for conducting the study. Some common 
reasons for conducting a study are: to fill a gap in the literature, a logical extension of previous work, or to 
answer an important clinical question. If other papers related to the same study have been published 
previously, please make sure to refer to them specifically. Describe the study methods in as much detail as 
possible so that others would be able to replicate the study should they need to. Results should describe the 
study sample as well as the findings from the study itself, but all interpretation of findings must be kept in 
the discussion section, which should consider primary outcomes first before any secondary or tertiary 
findings or post-hoc analyses. The conclusion should briefly summarise the main message of the paper and 
provide recommendations for further study. 
  
Select figures and tables for your paper carefully and sparingly. Use only those figures that provided added 
value to the paper, over and above what is written in the text. 
Do not replicate data in tables and in text . 
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Structured abstract 
• This should be 250-400 words, with the following recommended headings: 
◦ Background: why the study is being done and how it relates to other published work. 
◦ Objectives: what the study intends to find out 
◦ Methods: must include study design, number of participants, description of the intervention, 
primary and secondary outcomes, any specific analyses that were done on the data. 
◦ Results: first sentence must be brief population and sample description; outline the results 
according to the methods described. Primary outcomes must be described first, even if 
they are not the most significant findings of the study. 
◦ Conclusion: must be supported by the data, include recommendations for further study/actions. 
• Please ensure that the structured abstract is complete, accurate and clear and has been approved by all 
authors. 
• Do not include any references in the abstracts. 
  
  
Here is an example of a good abstract. 
  
Main article 
All articles are to include the following main sections: Introduction/Background, Methods, Results, 
Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
• Objectives (within Introduction/Background): a clear statement of the main aim of the study and the 
major hypothesis tested or research question posed 
• Design (within Methods): including factors such as prospective, randomisation, blinding, placebo 
control, case control, crossover, criterion standards for diagnostic tests, etc. 
• Setting (within Methods): level of care, e.g. primary, secondary, number of participating centres. 
• Participants (instead of patients or subjects; within Methods): numbers entering and completing the 
study, sex, age and any other biological, behavioural, social or cultural factors (e.g. smoking 
status, socioeconomic group, educational attainment, co-existing disease indicators, etc)that may 
have an impact on the study results. Clearly define how participants were enrolled, and describe 
selection and exclusion criteria. 
• Interventions (within Methods): what, how, when and for how long. Typically for randomised 
controlled trials, crossover trials, and before and after studies. 
• Main outcome measures (within Methods): those as planned in the protocol, and those ultimately 
measured. Explain differences, if any. 
  
Results 
• Start with description of the population and sample. Include key characteristics of comparison groups. 
• Main results with (for quantitative studies) 95% confidence intervals and, where appropriate, the exact 
level of statistical significance and the number need to treat/harm. Whenever possible, state 
absolute rather than relative risks. 
• Do not replicate data in tables and in text. 
• If presenting mean and standard deviations, specify this clearly. Our house style is to present this as 
follows: 
• E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± symbol for mean (SD). 
• Leave interpretation to the Discussion section. The Results section should just report the findings as per 
the Methods section. 
  
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-headings are not 
needed: 
• Statement of principal findings 
• Strengths and weaknesses of the study 
• Contribution to the body of knowledge 
• Strengths and weaknesses in relation to other studies 
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• The meaning of the study – e.g. what this study means to clinicians and policymakers 
• Unanswered questions and recommendations for future research 
  
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include primary conclusions and 




Guideline word limit: 1 000 words 
  
These opinion or comment articles are usually commissioned but we are happy to consider and peer review 
unsolicited editorials. Editorials should be accessible and interesting to readers without specialist 
knowledge of the subject under discussion and should have an element of topicality (why is a comment on 
this issue relevant now?) There should be a clear message to the piece, supported by evidence. 
Please make clear the type of evidence that supports each key statement, e.g.: 
• expert opinion 
• personal clinical experience 
• observational studies 
• trials 
• systematic reviews. 
  
CME (by invite only) 
CME is intended to provide readers with practical, up-to-date information on medical and related matters. 
It is aimed at those who are not specialists in the field. 
From January 2016, all CME articles will be printed in full in the SAMJ. Please try to adhere strictly to the 
guidelines on word count as we have a page limit for the print issue of the SAMJ. We reserve the right to 
place some tables and reference lists online if this is necessary for space. 
In practice, this means that each CME topic usually covers two issues of the print issue of the SAMJ. 
  
The guest editor, in consultation with the editor, is responsible for convening a team of authors, deciding 
on the subjects to be covered and for reviewing the manuscripts submitted. The suggestion is for 4 - 5 
articles, although there is some room for flexibility contingent on discussions with the editor. 
  
For queries about these guidelines please feel free to contact the CME editor, Dr Bridget Farham, by email 
(ugqirha@iafrica.com) or telephone (+27 (0)21 789 2331). 
  
Review process 
The guest editor reviews the articles and returns them to the CME editor for review and final approval. 
  
Guest editorials 
Guideline word limit: 1 000 words 
• Include the guest editor’s personal details (qualifications, positions, affiliation, e-mail address, and a 
short personal profile (50words)). 
• If possible, include a photograph of the author(s) at high enough resolution for print. It is preferable to 




Guideline word limit: 2 000 - 3 000 words 
• Each article requires an abstract of ±200 words. 
• The editor reserves the right to shorten articles but will send a substantially shortened article back for 
author approval. 
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Personal details 
Please supply: Your qualifications, position and affiliations and MP number (used for CPD points); 
Address, telephone number and fax number, and your e-mail address; and a short personal profile 
(50words)and a few words about your current fields of interest. 
  
In Practice 
Guideline word limit: 2 000 - 3 000words 
  
This section includes articles that would previously have been accepted into the Forum section, and case 
reports. 
In practice articles are those that draw attention to specific issues of clinical, economic or political interest 
regarding medicine and healthcare in southern Africa. They are assigned to a topic: 
  
• Case report 
• Clinical practice 
• Clinical alert 
• Issues in medicine 
• Issues in public health 
• Healthcare delivery 
• Consensus/Position statement 
• Medicine and the environment 
• Medicine and the law 
• Cochrane corner 
  
  
An In Practice article should follow the following format – sub-headings are not necessary, but may be 
used for clarity: 
• Author affiliations and qualifications: to be the same as for Research. Provide all authors’ names and 
initials, qualifications and full affiliations, and corresponding author. 
• Short abstract: does not need to be structured, but should capture the essential features of the article 
• Introduction: the reason for the article and the issue being addressed 
• Recent research, discussion, local policy around the issue – include your own research where 
appropriate 
• All statements should be referenced and, if opinion only, this should be stated 
• Discussion: how this article adds to the discussion around a particular topic 
• If a clinical practice or policy point is at issue, this needs to be emphasised, using a box with highlights 
if appropriate. 
  
Essentially In practice is an opportunity for a more discursive approach to topics of clinical, economic or 




The SAMJ has recently started to accept case reports. The cases must come from Africa, preferably 
southern Africa unless the condition is common to all African countries, and must be either a completely 
new description of a clinical condition or result (use Google!) or a case that highlights important practice 
or management issues. 
  
Please use the following format for case reports: 
• Title of case: do not include the words ‘a case report’ in the title 
• Summary/abstract:  up to 150 words summarising the case presentation and outcome 
• Background: why is this case important and why did you write it up? 
• Case presentation: presenting features, medical, social, family history as appropriate 
• Case management: should be according to best practice, and if not, please explain why 
• Investigations, if relevant: save space by simply saying ‘normal’ if, for example, renal function was 
completely normal, rather than listing normal results, highlight the abnormal – or indeed the 
normal if this is clinically significant 
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• Differential diagnosis, if relevant 
• Treatment, if relevant 
• Outcome and follow-up 
• Discussion – a VERY BRIEF review of similar published cases 
• Teaching points: 3 - 5 bullet points 
• References: as per the SAMJ house style 
• Tables and figures: keep to a minimum. Use clinical images where relevant – we need hi-res versions 
for print, and identifiable persons must have a consent form 
• Patient consent: please include a statement about patient consent to a written case report. This should be 
uploaded as a supplementary file. 
  
Clinical trials 
Guideline word limit: 4000 words 
  
As per the recommendations published by the International Committee of Medical Journal Editors 
(ICMJE), clinical trial research is any research that assigns individuals to an intervention, with or without a 
concurrent comparison/control group to study the cause-and-effect relationship between the intervention 
and health outcomes. All clinical trials should be registered with the appropriate national clinical trial 
registry (or any international primary register, if relevant), and the trial registration number should be cited 
at the end of the abstract. Since 1st December 2005, all clinical trials conducted in South Africa have been 
required to be registered in the South African National Clinical Trials Register. The SAMJ therefore 
requires that clinical trials be registered in the relevant public trials registry at or before the time of first 
patient enrollment as a condition for publication. The trial registry name and registration number must be 
included in the manuscript. 
  
Please refer to the general guidelines for all papers at the top of this article for additional requirements with 
respect to ethics approval, funding, author contributions, etc. The format of original research articles 
should be followed for reporting of clinical trial results. 
  
Review articles 
Guideline word limit: 4 000 words 
  
These are welcome, but should be either commissioned or discussed with the Editor before submission. A 
review article should provide a clear, up-to-date account of the topic and be aimed at non-specialist 
hospital doctors and general practitioners. 
  
Please ensure that your article includes: 
• Abstract: unstructured, of about 100-150 words, explaining the review and why it is important 
• Methods: Outline the sources and selection methods, including search strategy and keywords used for 
identifying references from online bibliographic databases. Discuss the quality of evidence. 
• When writing: clarify the evidence you used for key statements and the strength of the evidence. Do not 
present statements or opinions without such evidence, or if you have to, say that there is little or 
no evidence and that this is opinion. Avoid specialist jargon and abbreviations, and provide advice 
specific to southern Africa. 
• Personal details: Please supply your qualifications, position and affiliations and MP number (used for 
CPD points); address, telephone number and fax number, and your e-mail address; and a short 
personal profile (50 words) and a few words about your current fields of interest. 
  
Correspondence (Letters to the Editor) 
Guideline word limit: 500 words 
  
Letters to the editor should relate either to a paper or article published by the SAMJ or to a topical issue of 
particular relevance to the journal’s readership 
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• May include only one illustration or table 
• Must include a correspondence address. 
  
Book reviews 
Guideline word limit: 400 words 
Should be about 400 words and must be accompanied by the publication details of the book. Provide a hi-
res image of the cover if possible (with permission from the copyright holder). 
  
Obituaries 
Guideline word limit: 400 words 




Guidelines should always be discussed with the Editor prior to submission. 
  
Because of the intensive review process required to ensure Guidelines are independent, evidence-based 
and free from commercial bias, they are usually published as a supplement to the SAMJ, the costs of which 
must be covered by sponsorship, advertising or payment by the guideline authors/association. We will 
provide a quote based on the expected length of the guideline and whether it is to appear online only, or in 
print, which must be accepted by the body putting the guidelines together before submitting the work to 
the SAMJ. 
  
The Editor reserves the right to determine the scheduling of supplements. Understandably, a delay in 
publication must be anticipated dependent upon editorial workflow. 
  
All guidelines should be structured according to Agree II. 
Please access this website before putting the guidelines together, download the Agree 11 instrument and 
use this to put the guidelines together. 
All submitted guidelines will be sent to the local Agree II appraisal committee for review and must be 
endorsed by an appropriate body prior to consideration and all conflicts of interest expressed. 
  
A structured abstract not exceeding 400 words (recommended sub-headings: Background, 
Recommendations, Conclusion) is required. Sections and sub-sections must be numbered consecutively 
(e.g. 1. Introduction; 1.1 Definitions; 2.etc.) and summarised in a Table of Contents. 
  
Illustrations/photos/scans 
• If illustrations submitted have been published elsewhere, the author(s) should provide consent to 
republication obtained from the copyright holder. 
• Figures must be numbered in Arabic numerals and referred to in the text e.g. '(Fig. 1)'. 
• Each figure must have a caption/legend: Fig. 1. Description (any abbreviations in full). 
• All images must be of high enough resolution/quality for print. 
• All illustrations (graphs, diagrams, charts, etc.) must be in PDF form. 
• Ensure all graph axes are labelled appropriately, with a heading/description and units (as necessary) 
indicated. Do not include decimal places if not necessary e.g. 0; 1.0; 2.0; 3.0; 4.0 etc. 
• Scans/photos showing a specific feature e.g. Intermediate magnification micrograph of a low malignant 
potential (LMP) mucinous ovarian tumour. (H&E stain). –include an arrow to show the tumour. 
• Each image must be attached individually as a 'supplementary file' upon submission (not solely 
embedded in the accompanying manuscript) and named Fig. 1, Fig. 2, etc. 
  
Tables 
• Tables should be constructed carefully and simply for intelligible data representation. Unnecessarily 
complicated tables are strongly discouraged. 
• Large tables will generally not be accepted for publication in their entirety. Please consider shortening 
and using the text to highlight specific important sections, or offer a large table as an addendum to 
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the publication, but available in full on request from the author 
• Embed/include each table in the manuscript Word file - do not provide separately as supplementary 
files. 
• Number each table in Arabic numerals (Table 1, Table 2, etc.) and refer to consecutively in the text. 
• Tables must be cell-based (i.e. not constructed with text boxes or tabs) and editable. 
• Ensure each table has a concise title and column headings, and include units where necessary. 
• Footnotes must be indicated with consecutive use of the following symbols: * † ‡ § ¶ || then ** †† ‡‡ 
etc. 
  
Do not: Use [Enter] within a row to make ‘new rows’: 
  
Rather: 
Each row of data must have its own proper row: 
  
Do not: use separate columns for n and %: 
  
Rather: 
Combine into one column, n (%): 
  
Do not: have overlapping categories, e.g.: 
  
Rather: 




NB: Only complete, correctly formatted reference lists in Vancouver style will be accepted. Reference 
lists must be generated manually and not with the use of reference manager software. Endnotes must not 
be used. 
• Authors must verify references from original sources. 
• Citations should be inserted in the text as superscript numbers between square brackets, e.g. These 
regulations are endorsed by the World Health Organization,[2] and others.[3,4-6] 
• All references should be listed at the end of the article in numerical order of appearance in the 
Vancouver style (not alphabetical order). 
• Approved abbreviations of journal titles must be used; see the List of Journals in Index Medicus. 
• Names and initials of all authors should be given; if there are more than six authors, the first three 
names should be given followed by et al. 
• Volume and issue numbers should be given. 
• First and last page, in full, should be given e.g.: 1215-1217 not 1215-17. 
• Wherever possible, references must be accompanied by a digital object identifier (DOI) link). Authors 
are encouraged to use the DOI lookup service offered by CrossRef: 
◦ On the Crossref homepage, paste the article title into the ‘Metadata search’ box. 
◦ Look for the correct, matching article in the list of results. 
◦ Click Actions > Cite 
◦ Alongside 'url =' copy the URL between { }. 
◦ Provide as follows, e.g.: https://doi.org/10.7196/07294.937.98x 
  
Some examples: 
• Journal references: Price NC, Jacobs NN, Roberts DA, et al. Importance of asking about glaucoma. Stat 
Med 1998;289(1):350-355. http://dx.doi.org/10.1000/hgjr.182 
• Book references: Jeffcoate N. Principles of Gynaecology. 4th ed. London: Butterworth, 1975:96-101. 
• Chapter/section in a book: Weinstein L, Swartz MN. Pathogenic Properties of Invading 
Microorganisms. In: Sodeman WA, Sodeman WA, eds. Pathologic Physiology: Mechanisms of 
Disease. Philadelphia: WB Saunders, 1974:457-472. 
• Internet references: World Health Organization. The World Health Report 2002 - Reducing Risks, 
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Promoting Healthy Life. Geneva: WHO, 2002. http://www.who.int/whr/2002 (accessed 16 
January 2010). 
• Legal references 
•              Government Gazettes: 
National Department of Health, South Africa. National Policy for Health Act, 1990 (Act No. 116 of 1990). 
Free primary health care services. Government Gazette No. 17507:1514. 1996. 
In this example, 17507 is the Gazette Number. This is followed by :1514 - this is the notice number in this 
Gazette. 
•              Provincial Gazettes: 
Gauteng Province, South Africa; Department of Agriculture, Conservation, Environment and Land Affairs. 
Publication of the Gauteng health care waste management draft regulations. Gauteng Provincial Gazette 
No. 373:3003, 2003. 
•              Acts: 
South Africa. National Health Act No. 61 of 2003. 
•              Regulations to an Act: 
South Africa. National Health Act of 2003. Regulations: Rendering of clinical forensic medicine services. 
Government Gazette No. 35099, 2012. (Published under Government Notice R176). 
•              Bills: 
South Africa. Traditional Health Practitioners Bill, No. B66B-2003, 2006. 
•              Green/white papers: 
South Africa. Department of Health Green Paper: National Health Insurance in South Africa. 2011. 
•              Case law: 
Rex v Jopp and Another 1949 (4) SA 11 (N) 
Rex v Jopp and Another:  Name of the parties concerned 
1949: Date of decision (or when the case was heard) 
(4): Volume number 
SA: SA Law Reports 
11: Page or section number 
(N): In this case Natal - where the case was heard. Similarly, (C) woud indicate Cape, (G) Gauteng, and so 
on. 
NOTE: no . after the v 
• Other references (e.g. reports) should follow the same format: Author(s). Title. Publisher place: 
Publisher name, year; pages. 
• Cited manuscripts that have been accepted but not yet published can be included as references followed 
by '(in press)'. 
• Unpublished observations and personal communications in the text must not appear in the reference list. 
The full name of the source person must be provided for personal communications e.g. '...(Prof. 
Michael Jones, personal communication)'. 
  
From submission to acceptance 
Submission and peer-review 
To submit an article: 
• Please ensure that you have prepared your manuscript in line with the SAMJ requirements. 
• All submissions should be submitted via Editorial Manager 
• The following are required for your submission to be complete: 
◦ Anonymous manuscript (unless otherwise stated) 
◦ Author Agreement form 
◦ Manuscript 
◦ Any supplementary files: figures, datasets, patient consent form, permissions for published 
images, etc. 
• Once the submission has been successfully processed on Editorial Manager, it will undergo a technical 
check by the Editorial Office before it will be assigned to an editor who will handle the review 
process. If the author guidelines have not been appropriately followed, the manuscript may be sent 








The following process should usually take between 4 - 6 weeks: 
1 An accepted manuscript is passed to a Managing Editor to assign to a copyeditor (CE). 
2 The CE copyedits in Word, working on house style, format, spelling/grammar/punctuation, sense and 
consistency, and preparation for typesetting. 
3 If the CE has an author queries, he/she will contact the corresponding author and send them the 
copyedited Word doc, asking them to solve the queries by means of track changes or comment 
boxes. 
4 The authors are typically asked to respond within 1-3 days. Any comments/changes must be clearly 
indicated e.g. by means of track changes. Do not work in the original manuscript - work in the 
copyedited file sent to you and make your changes clear. 
5 The CE will finalise the article and then it will be typeset. 
6 Once typeset, the CE will send a PDF of the file to the authors to complete their final check, while 
simultaneously sending to the 2nd-eye proofreader. 
7 The authors are typically asked to complete their final check and sign-off within 1-2 days. No major 
additional changes can be accommodated at this point. 
8 The CE implements the authors’ and proofreader’s mark-ups, finalises the file, and prepares it for the 
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upcoming issue. 
  
Changing contact details or authorship 





Online v. print 
The SAMJ is an online journal. The online version of the journal is the one that has the widest circulation, 
is indexed by bibliographic databases including PubMed and SciELO, and is accessible in academic 
libraries. A printed edition , containing material selected by the Editor is also published each month and 




• The full text of all accepted articles is published in full online, open access, within 4 - 6 weeks of 
acceptance. 
• Citation information of each article is based on its online publication. 
• You may want to make use of the advantages of online publication e.g. specify web links to other 
sources, images, data or even a short video. 
  
Print 
• Not all articles will be selected for print. 
• An article may be selected for print in a different month from that in which it was published online. 
• Research articles will appear in abstract form only, if selected for a print edition. 
  
Errata and retractions 
Errata 
Should you become aware of an error or inaccuracy in yours or someone else’s contribution after it has 
been published, please inform us as soon as possible via an email to publishing@hmpg.co.za,including the 
following details: 
• Journal, volume and issue in which published 
• Article title and authors 
• Description of error and details of where it appears in the published article 
• Full detail of proposed correction and rationale 
  
We will investigate the issue and provide feedback. If appropriate, we will correct the web version 
immediately, and will publish anerratum  in the next issue. The correction will be indexed, as PubMed has 
a function for linking errata back to the original article. All investigations will be conducted in accordance 
with guidelines provided by the Committee on Publication Ethics (COPE). 
  
Retractions 
Retraction of an article is the prerogative of either the original authors or the editorial team of HMPG. 
Should you wish to withdraw your article before publication, we need a signed statement from all the 
authors. 
  
Should you wish to retract your published article, all authors have to agree in writing before publication of 
the retraction. 
Send an email to publishing@hmpg.co.za, including the following details: 
• Journal, volume and issue to which article was submitted/in which article was published 
• Article title and authors 
• Description of reason for withdrawal/retraction. 
  
We will make a decision on a case-by-case basis upon review by the editorial committee in line with 
international best practices. Comprehensive feedback will be communicated with the authors with regard 
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to the process. In case where there is any suspected fraud or professional misconduct, we will follow due 
process as recommended by the Committee on Publication Ethics (COPE), and in liaison with any relevant 
institutions. 
  
When a retraction is published, it will be linked to the original article. 
  
Indexing 
The SAMJ has an impact factor of 1.5. 
Published articles are covered by the following major indexing services. As such articles published in the 
SAMJ are immediately available to all users of these databases, guaranteed a global and African audience: 
• Index Medicus (Medline/PubMed)  
• ExcerptaMedica (EMBASE) 
• Biological Abstracts (BIOSIS) 
• Science Citation Index (SciSearch) 









Contact claudian@hmpg.co.za for information on submitting ad hoc/commissioned supplements, including 




Submission Preparation Checklist 
As part of the submission process, authors are required to check off their submission's compliance with all 
of the following items, and submissions may be returned to authors that do not adhere to these guidelines. 
1 Named authors consent to publication and meet the requirements of authorship as set out by the journal. 
2 The submission has not been previously published, nor is it before another journal for consideration. 
3 The text complies with the stylistic and bibliographic requirements in Author Guidelines. 
4 The manuscript is in Microsoft Word or RTF document format. The text is single-spaced, in 12-point 
Times New Roman font, and contains no unnecessary formatting. 
5 Illustrations/figures are high resolution/quality (not compressed) and in an acceptable format (preferably 
TIFF or PNG). These must be submitted individually as 'supplementary files' (not solely 
embedded in the manuscript). 
6 For illustrations/figures or tables that have been published elsewhere, the author has obtained written 
consent to republication from the copyright holder. 
7 Where possible, references are accompanied by a digital object identifier (DOI) and PubMed ID 
(PMID)/PubMed Central ID (PMCID). 
8 An abstract has been included where applicable. 
9 The research was approved by a Research Ethics Committee (if applicable) 




Copyright of published material remains in the Authors’ name. This allows authors to use their work for 
their own non-commercial purposes without seeking permission from the Publisher, subject to properly 
acknowledging the Journal as the original place of publication. 
 Authors are free to copy, print and distribute their articles, in full or in part, for teaching activities, and to 
deposit or include their work in their own personal or institutional database or on-line website. Authors are 
requested to inform the Journal/Publishers of their desire/intention to include their work in a thesis or 
dissertation or to republish their work in any derivative form (but not for commercial use).  
 Material submitted for publication in the SAMJ is accepted provided it has not been published or 
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submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper 




The SAMJ is committed to protecting the privacy of the users of this journal website. The names, personal 
particulars and email addresses entered in this website will be used only for the stated purposes of this 
journal and will not be made available to third parties without the user’s permission or due process. Users 
consent to receive communication from the SAMJ for the stated purposes of the journal. Queries with 
regard to privacy may be directed to publishing@hmpg.co.za. 
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